Literature DB >> 33420777

Heterogeneity in DSM-5 Symptom Criteria: Phenotypes of Alcohol Use Disorder in a Sample Seeking Alcohol Treatment.

Junru Zhao1, Braden Linn2, Clara Bradizza1, Joseph Lucke3, Melanie Ruszczyk1, Paul Stasiewicz1.   

Abstract

AIMS: This study sought to identify phenotypic variations among individuals with alcohol use disorder (AUD) that may, in part, help improve the effectiveness of existing AUD interventions.
METHODS: Latent class analysis was conducted to examine the potential heterogeneity of AUD in a sample (N = 220; Mage = 51.19 years, standard deviation = 9.94; 37.7% female) of treatment-seeking participants diagnosed with AUD using DSM-5 criteria. RESULTS AND
CONCLUSIONS: Three distinct patterns of responses to the 11 DSM-5 AUD symptoms emerged: Class 1 (n = 114, 51.8%), Class 2 (n = 78, 35.5%) and Class 3 (n = 28, 12.7%). The identified profiles were further differentiated by demographics, alcohol-related constructs, individual difference characteristics and diagnostic and treatment variables. The findings have implications for refining AUD assessment as well as optimizing personalized treatment.
© The Author(s) 2021. Medical Council on Alcohol and Oxford University Press. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33420777      PMCID: PMC8557689          DOI: 10.1093/alcalc/agaa138

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  31 in total

1.  A latent class analysis of DSM-IV alcohol use disorder criteria and binge drinking in undergraduates.

Authors:  Cheryl L Beseler; Laura A Taylor; Deborah T Kraemer; Robert F Leeman
Journal:  Alcohol Clin Exp Res       Date:  2011-10-17       Impact factor: 3.455

2.  "Success" following alcohol treatment: moving beyond abstinence.

Authors:  Katie Witkiewitz
Journal:  Alcohol Clin Exp Res       Date:  2012-10-17       Impact factor: 3.455

3.  Adolescent Predictors of a Typology of DSM-5 Alcohol Use Disorder Symptoms in Young Adults Derived by Latent Class Analysis Using Data From an Australian Cohort Study.

Authors:  Wendy Swift; Tim Slade; Natacha Carragher; Carolyn Coffey; Louisa Degenhardt; Wayne Hall; George Patton
Journal:  J Stud Alcohol Drugs       Date:  2016-09       Impact factor: 2.582

4.  DSM-5 latent classes of alcohol users in a population-based sample: results from the São Paulo Megacity Mental Health Survey, Brazil.

Authors:  João Mauricio Castaldelli-Maia; Camila M Silveira; Erica R Siu; Yuan-Pang Wang; Igor A Milhorança; Clóvis Alexandrino-Silva; Guilherme Borges; Maria C Viana; Arthur G Andrade; Laura H Andrade; Silvia S Martins
Journal:  Drug Alcohol Depend       Date:  2014-01-03       Impact factor: 4.492

5.  DSM-5 Latent Classes of Alcohol Users among Treatment Seeking Older Adults.

Authors:  Anna Mejldal; Kjeld Andersen; Randi Bilberg; Sören Möller; Anette Søgaard Nielsen
Journal:  Subst Use Misuse       Date:  2020-02-28       Impact factor: 2.164

6.  Latent Class Analysis of DSM-5 Alcohol Use Disorder Criteria Among Heavy-Drinking College Students.

Authors:  Dipali Venkataraman Rinker; Clayton Neighbors
Journal:  J Subst Abuse Treat       Date:  2015-05-16

7.  Moving the Alcohol Addiction RDoC forward.

Authors:  Kenneth J Sher
Journal:  Alcohol Clin Exp Res       Date:  2015-02-06       Impact factor: 3.455

8.  Longitudinal phenotypes for alcoholism: Heterogeneity of course, early identifiers, and life course correlates.

Authors:  Jennifer M Jester; Anne Buu; Robert A Zucker
Journal:  Dev Psychopathol       Date:  2015-12-10

9.  Lapses following alcohol treatment: modeling the falls from the wagon.

Authors:  Katie Witkiewitz
Journal:  J Stud Alcohol Drugs       Date:  2008-07       Impact factor: 2.582

10.  The Addictions Neuroclinical Assessment Negative Emotionality Domain Among Treatment-Seekers with Alcohol Use Disorder: Construct Validity and Measurement Invariance.

Authors:  Victoria R Votaw; Matthew R Pearson; Elena Stein; Katie Witkiewitz
Journal:  Alcohol Clin Exp Res       Date:  2020-02-06       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.